ScoreWhy is Supriya Lifescience Ltd ?
1
High Management Efficiency with a high ROE of 17.74%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.89% and Operating profit at 7.16% over the last 5 years
4
Flat results in Sep 25
5
With ROE of 18.3, it has a Very Expensive valuation with a 6 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -6.94%, its profits have risen by 15.8% ; the PEG ratio of the company is 2.1
6
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.96% over the previous quarter and collectively hold 10.68% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Supriya Lifesci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Supriya Lifesci. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
-4.5%
-0.16
44.74%
Sensex
4.65%
0.45
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.89%
EBIT Growth (5y)
7.16%
EBIT to Interest (avg)
74.85
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.70
Tax Ratio
24.75%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
10.68%
ROCE (avg)
28.52%
ROE (avg)
17.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
34
Price to Book Value
6.01
EV to EBIT
25.32
EV to EBITDA
22.95
EV to Capital Employed
6.41
EV to Sales
8.28
PEG Ratio
2.08
Dividend Yield
0.13%
ROCE (Latest)
26.04%
ROE (Latest)
18.30%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(Q)
Highest at Rs 199.83 cr
PBDIT(Q)
Highest at Rs 72.64 cr.
PBT LESS OI(Q)
Highest at Rs 65.59 cr.
PAT(Q)
Highest at Rs 50.43 cr.
EPS(Q)
Highest at Rs 6.26
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Supriya Lifesci.
Net Sales - Quarterly
Highest at Rs 199.83 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 72.64 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 65.59 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 50.43 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 6.26
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
